University of Birmingham: 4D Medicine Appoints Andrew Newland as Chair to Drive Next Phase of Growth
August 01, 2026
August 01, 2026
BIRMINGHAM, England, Aug. 1 -- The University of Birmingham posted the following news:
* * *
4D Medicine appoints Andrew Newland as Chair to drive next phase of growth
Andrew Newland will lead the Board to FDA clearance for 4D's first nerve protection products, prepare for a Series B raise, and a launch in the US market.
-
4D Medicine Ltd, a Series A-stage medical device and biomaterials company primarily focused on advancing . . .
* * *
4D Medicine appoints Andrew Newland as Chair to drive next phase of growth
Andrew Newland will lead the Board to FDA clearance for 4D's first nerve protection products, prepare for a Series B raise, and a launch in the US market.
-
4D Medicine Ltd, a Series A-stage medical device and biomaterials company primarily focused on advancing . . .